跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
乐唯初 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Nirsevimab Injection
Approved
生物制品
Nirsevimab Injection
SANOFI WINTHROP INDUSTRIE
🇨🇳 National Medical Products Administration
Approval Date
Dec 26, 2023
Approval ID
8WHZfUIKGVx
Company
SANOFI WINTHROP INDUSTRIE
Type
生物制品
Approval Details
Approval Id
8WHZfUIKGVx
Approval Number
国药准字SJ20230021
Generic Name
尼塞韦单抗注射液
Generic Name En
Nirsevimab Injection
Trade Name
乐唯初
Drug Type
生物制品
Dosage Form
注射剂
Strength
50mg(0.5ml)/支(预充式注射器)
Reg Date
2023-12-26
Expired Date
2028-12-25
Company Name
SANOFI WINTHROP INDUSTRIE
Production Company Name
Patheon Manufacturing Services LLC
Company Detail Path
/organization/sanofi-winthrop-industrie
Production Company Detail Path
/organization/patheon-manufacturing-services-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 26, 2023
Approval ID
8WHZfUIKGVx
Type
生物制品
Back to NMPA Approvals